Aortic stenosis is the obstruction of blood flow across the aortic valve. Among symptomatic patients with medically treated moderate-to-severe aortic stenosis, mortality from the onset of symptoms is approximately 25% at 1 year and 50% at 2 years. Symptoms of aortic stenosis usually develop gradually after an asymptomatic latent period of 10-20 years.
DelveInsight’s ‘‘Aortic Stenosis Market Insights, Epidemiology and Market Forecast-2030’’ report delivers an in-depth understanding of the Aortic Stenosis, historical and forecasted epidemiology as well as the Aortic Stenosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some key facts of Aortic Stenosis Market:
Scope of the Aortic Stenosis Market Report:
Request for Sample Page: https://www.delveinsight.com/sample-request/aortic-stenosis-market
Some of Aortic Stenosis Companies are:
Aortic Stenosis therapies are:
Table of contents:
1. Key Insights
2. Executive Summary of Aortic Stenosis
3. Competitive Intelligence Analysis for Aortic Stenosis
4. Aortic Stenosis: Market Overview at a Glance
4.1. Aortic Stenosis Total Market Share (%) Distribution in 2018
4.2. Aortic Stenosis Total Market Share (%) Distribution in 2030
5. Aortic Stenosis: Disease Background and Overview
5.1. Introduction
5.2. Sign and Symptoms
5.3. Pathophysiology
5.4. Risk Factors
5.5. Diagnosis
6. Patient Journey
7. Aortic Stenosis Epidemiology and Patient Population
7.1. Epidemiology Key Findings
7.2. Assumptions and Rationale: 7MM
7.3. Epidemiology Scenario: 7MM
7.3.1. Aortic Stenosis Epidemiology Scenario in the 7MM (2018-2030)
7.4. United States Epidemiology
7.4.1. Aortic Stenosis Epidemiology Scenario in the United States (2018-2030)
7.5. EU-5 Country-wise Epidemiology
7.5.1. Germany Epidemiology
7.5.1.1. Aortic Stenosis Epidemiology Scenario in Germany (2018-2030)
7.5.2. France Epidemiology
7.5.2.1. Aortic Stenosis Epidemiology Scenario in France (2018-2030)
7.5.3. Italy Epidemiology
7.5.3.1. Aortic Stenosis Epidemiology Scenario in Italy (2018-2030)
7.5.4. Spain Epidemiology
7.5.4.1. Aortic Stenosis Epidemiology Scenario in Spain (2018-2030)
7.5.5. United Kingdom Epidemiology
7.5.5.1. Aortic Stenosis Epidemiology Scenario in the United Kingdom (2018-2030)
7.5.6. Japan Epidemiology
7.5.6.1. Aortic Stenosis Epidemiology Scenario in Japan (2018-2030)
8. Treatment Algorithm, Current Treatment, and Medical Practices
8.1. Aortic Stenosis Treatment and Management
8.2. Aortic Stenosis Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of Aortic Stenosis Treatment
11. Marketed Products
11.1. List of Marketed Products in the 7MM
11.2. Drug Name: Company Name
11.2.1. Product Description
11.2.2. Regulatory Milestones
11.2.3. Other Developmental Activities
11.2.4. Pivotal Clinical Trials
11.2.5. Summary of Pivotal Clinical Trial
List to be continued in report
12. Emerging Therapies
12.1. Key Cross
12.2. Drug Name: Company Name
12.2.1. Product Description
12.2.2. Other Developmental Activities
12.2.3. Clinical Development
12.2.4. Safety and Efficacy
12.2.5. Product Profile
13. Aortic Stenosis: Seven Major Market Analysis
13.1. Key Findings
13.2. Aortic Stenosis Market Size in 7MM
13.3. Aortic Stenosis Market Size by Therapies in the 7MM
14. Attribute analysis
15. 7MM: Market Outlook
15.1. United States: Market Size
15.1.1. Aortic Stenosis Total Market Size in the United States
15.1.2. Aortic Stenosis Market Size by Therapies in the United States
15.2. EU-5 countries: Market Size and Outlook
15.3. Germany Market Size
15.3.1. Aortic Stenosis Total Market Size in Germany
15.3.2. Aortic Stenosis Market Size by Therapies in Germany
15.4. France Market Size
15.4.1. Aortic Stenosis Total Market Size in France
15.4.2. Aortic Stenosis Market Size by Therapies in France
15.5. Italy Market Size
15.5.1. Aortic Stenosis Total Market Size in Italy
15.5.2. Aortic Stenosis Market Size by Therapies in Italy
15.6. Spain Market Size
15.6.1. Aortic Stenosis Total Market Size in Spain
15.6.2. Aortic Stenosis Market Size by Therapies in Spain
15.7. United Kingdom Market Size
15.7.1. Aortic Stenosis Total Market Size in the United Kingdom
15.7.2. Aortic Stenosis Market Size by Therapies in the United Kingdom
15.8. Japan Market Outlook
15.8.1. Japan Market Size
15.8.2. Aortic Stenosis Total Market Size in Japan
15.8.3. Aortic Stenosis Market Size by Therapies in Japan
16. Access and Reimbursement Overview of Aortic Stenosis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight Capabilities
22. Disclaimer
Request for Detailed TOC: https://www.delveinsight.com/sample-request/aortic-stenosis-market
About DelveInsight
DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/aortic-stenosis-market